Research location
Baoding
Hebei, China
Advertisement
Research activity in Baoding
Hebei, ChinaCureCurrent currently publishes aggregate city-level research activity for this location: 68 trials and 79 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Baoding
68 linked trials · page 1 of 2BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic DiseaseNCT07492641 · 2026-05-22 · 1 site observation
RECRUITING
Efficacy and Mechanisms of Escitalopram in Drug-Naïve First-Episode Major Depressive DisorderNCT07480525 · 2026-03-20 · 1 site observation
RECRUITING
JS207 Combination Therapy in Triple-negative Breast CancerNCT07045311 · 2025-09-17 · 1 site observation
RECRUITING
A Study of YL202 in Combination With Other Anti-tumor Therapies in Patients With Advanced Solid TumorsNCT07169994 · 2025-09-02 · 1 site observation
RECRUITING
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.NCT07062965 · 2025-08-05 · 1 site observation
RECRUITING
A Trial Comparing GQ1005 and T-DM1 in Patients With HER2-Positive Unresectable or Metastatic Breast CancerNCT07673029 · 2025-01-10 · 1 site observation
RECRUITING
D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standard Therapy FailureNCT06300177 · 2024-03-28 · 1 site observation
RECRUITING
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)NCT05920356 · 2023-11-16 · 1 site observation
RECRUITING
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid TumorsNCT05914116 · 2023-08-17 · 1 site observation
RECRUITING
SHengXIaN-QuYu DEcoction in Heart Failure With Reduced and Mildly Reduced Ejection FractionNCT05583773 · 2023-03-29 · 1 site observation
RECRUITING
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)NCT04928846 · 2022-03-25 · 1 site observation
RECRUITING
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid TumorsNCT05150691 · 2022-01-31 · 1 site observation
RECRUITING
Adjuvant Chemotherapy for High Malignant Prostate CancerNCT06864533 · 2019-09-01 · 1 site observation
RECRUITING
Study of MCLA-129 in the Treatment of Advanced Non-small Cell Lung Cancer with AGA and MET Amplification.NCT06885840 · 2025-03-31 · 1 site observation
NOT_YET_RECRUITING
A Phase II Study to Evaluate NH102 for DepressionNCT06842992 · 2024-12-04 · 1 site observation
COMPLETED
Efficacy and Safety Study of Levomilnacipran Hydrochloride Extended-Release Capsules in Major Depressive DisorderNCT07253207 · 2024-10-17 · 1 site observation
COMPLETED
A Clinical Trial of TQB2102 for Injection in the Treatment of HER2 Low-Expressing Recurrent/Metastatic Breast CancerNCT06561607 · 2024-10-11 · 1 site observation
ACTIVE_NOT_RECRUITING
HTA of NIVATS Based on RWENCT06574295 · 2024-08-20 · 1 site observation
COMPLETED
PM8002 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally Advanced/Metastatic TNBCNCT06419621 · 2024-06-11 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Compare DB-1303/BNT323 Versus T-DM1 in Breast CancerNCT06265428 · 2024-01-29 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02)NCT06018337 · 2024-01-18 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of the Effectiveness and Safety of JS1-1-01 in Patients With Moderate to Severe DepressionNCT06259526 · 2023-12-26 · 1 site observation
COMPLETED
A Study of AK104/Tislelizumab With Chemotherapy as First-line Treatment in PD-L1 TPS < 1% Non-small Cell Lung CancerNCT05990127 · 2023-11-14 · 1 site observation
NOT_YET_RECRUITING
pBFS Guided VS "5-cm Rule" rTMS Over DLPFC for MDDNCT05964023 · 2023-08-20 · 1 site observation
UNKNOWN
pBFS-guided High-dose TMS Over DMPFC for Treatment-resistant Major Depressive DisorderNCT05964036 · 2023-07-21 · 1 site observation
UNKNOWN
pBFS Guided rTMS Over DMPFC for Treatment-Resistant DepressionNCT05948839 · 2023-07-11 · 1 site observation
UNKNOWN
Evaluation of the Efficacy and Safety of AL2846 Capsule Combined With TQB2450 Injection Compared to Docetaxel Injection in Advanced Non-small Cell Lung Cancer Patients Who Have Failed With Immunotherapy.NCT05922345 · 2023-06-08 · 1 site observation
UNKNOWN
A Study to Assess the Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Chinese Adult Subjects With DSM-5 SchizophreniaNCT05919823 · 2023-05-29 · 1 site observation
COMPLETED
Evaluation of the Effect of Injectable Neucardin on Cardiac Function and Reversal Ventricular Remodeling in Patients With Chronic Systolic Heart FailureNCT05949801 · 2023-04-13 · 1 site observation
COMPLETED
FS-1502 Versus T-DM1 for HER2-Positive Unresectable Locally Advanced or Metastatic Breast CancerNCT05755048 · 2023-03-28 · 1 site observation
UNKNOWN
A Study of Tislelizumab in Combination With Investigational Agents in Participants With Non-Small Cell Lung CancerNCT05635708 · 2023-03-07 · 1 site observation
ACTIVE_NOT_RECRUITING
The Development and Study of a 3D-Printed Model for Surgical Planning of Lung Cancer with Realistic Subsegmental Boundaries and Complete Tissue StructuresNCT06507774 · 2023-01-01 · 1 site observation
COMPLETED
To Evaluate the Efficacy and Safety of TQB3616 in Combination With Fulvestrant Versus Placebo in Combination With Fulvestrant in Previously Untreated Hormone-receptor (HR)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Advanced Breast CancerNCT05365178 · 2022-07-01 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Evaluate the Efficacy and Safety of Serplulimab in Combination With Chemotherapy and Concurrent Radiotherapy in Patients With Limited-Stage Small Cell Lung CancerNCT05353257 · 2022-05-17 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Evaluate the Efficacy and Safety of HLX11 vs. EU-Perjeta® in the Neoadjuvant Therapy of HER2-Positive and HR-Negative Early-stage or Locally Advanced Breast CancerNCT05346224 · 2022-04-25 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast CancerNCT05132582 · 2022-03-07 · 1 site observation
ACTIVE_NOT_RECRUITING
Study to Evaluate Efficacy & Safety of Afuresertib Plus Fulvestrant in Patients With Locally Advanced or Metastatic HR+/HER2- Breast CancerNCT04851613 · 2022-02-18 · 1 site observation
ACTIVE_NOT_RECRUITING
Long-term Efficacy and Safety Study of GV-971NCT05181475 · 2021-12-07 · 1 site observation
ACTIVE_NOT_RECRUITING
Trial of Chidamide in Combination With Envafolimab in Patients With PD-1 Inhibitor Resistant Advanced NSCLC.NCT05068427 · 2021-11-23 · 1 site observation
COMPLETED
A Study of Mitoxantrone Hydrochloride Liposome Injection in Patients With Advanced HER2 Negative Breast CancerNCT04927481 · 2021-06-11 · 1 site observation
TERMINATED
Camrelizumab Combined With SRT/WBRT and Chemotherapy in Patients With Brain Metastases of Driven Gene-negative NSCLCNCT04768075 · 2021-05-28 · 1 site observation
COMPLETED
Dance/Movement Therapy for Bone Mineral Density in SchizophreniaNCT05716802 · 2020-07-07 · 1 site observation
COMPLETED
A BRIDGING STUDY OF PF-06439535 (CN) PLUS PACLITAXEL-CARBOPLATIN VERSUS BEVACIZUMAB PLUS PACLITAXEL-CARBOPLATIN IN NSCLCNCT04325698 · 2020-06-11 · 1 site observation
TERMINATED
Comparison of Anyu Peibo With Placebo in Treatment of MDD in ChinaNCT04210973 · 2020-01-23 · 1 site observation
UNKNOWN
Cancer Genome Atlas of China:Lung CancerNCT04266483 · 2019-11-08 · 1 site observation
UNKNOWN
A Randomized, Double-blind, Placebo Controlled Phase III Study to Investigate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy (Carboplatin-Nanoparticle Albumin Bound (Nab) Paclitaxel) in Patients With Stage IIIB/IIIC or IV NSCLCNCT04033354 · 2019-08-14 · 1 site observation
UNKNOWN
Study of Experience of High-frequency Repetitive TranscranialNCT05809882 · 2019-03-01 · 1 site observation
COMPLETED
Study to Explore the Effective Doses and to Assess the Safety and Efficacy of Hypidone Hydrochloride TabletsNCT03739632 · 2018-11-30 · 1 site observation
COMPLETED
Circulating Tumor DNA Longitudinal Monitoring in Stage III-IV Lung Cancer PatientsNCT03664843 · 2018-11-09 · 1 site observation
UNKNOWN
Study of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung CancerNCT03539536 · 2018-10-10 · 1 site observation
ACTIVE_NOT_RECRUITING
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.